Şunu aradınız:: metastatic (İngilizce - Maltaca)

metastatic population
popolazzjoni b’marda avanzata lokalment

≥2 metastatic sites
≥2 siti metastatċi

metastatic disease, n (%)
mard metastatiku, n (%)

metastatic breast cancer
kanċer tas-sider fl-istat metastatiku

metastatic disease at baseline
marda metastatika fillinja bażi

neoplasm swelling, metastatic pain
nefħa tan- neoplażma, uġigħ metastatiku

metastatic breast cancer (mbc)
kanċer tas-sider li mmetastatizza (mbc)

20% had metastatic prostate cancer
20% kellhom kanċer tal-prostata metastatiku

metastatic breast or ovarian cancer
kanċer ovarjan jew tas-sider fl-istat metastatiku:

7% had an unknown metastatic status
7% kellhom stat metastatiku mhux magħruf

metastatic pain, tumour necrosis common:
kontużjoni korriment u avvelenament u komplikazzjonijiet ta ’ xi proċedura:

metastatic cancer of the large intestine.
kanċer metastatiku tal-musrana l-kbira.

cancer patients with metastatic bone disease)
riżultati ta ’ l- effikaċja sekondarja (pazjenti b’ kanċer tas- sider bil- mard metastatiku fl- għadam)

cytokine-refractory metastatic renal cell carcinoma
karċinoma metastatika refrattarja għaċ-ċitokini

clinical studies in unresectable and/or metastatic gist
provi kliniċi fuq gist li ma jkunx jista’ jitneħħa b’operazzjoni u/jew huwa metastatiku

metastatic carcinoma of the colon or rectum (mcrc)
karċinoma tal-kolon jew tar-rektum li mmetastatizzat (mcrc)

advanced and/or metastatic renal cell cancer (mrcc)
kanċer avvanzat u/jew metastatiku taċ-ċelluli renali (mrcc)

bo17929 - single-arm trial in metastatic breast cancer
bo17929 – prova bi grupp wieħed dwar kanċer metastatiku tas-sider

metastatic disease progression was inhibited and microvascular permeability was reduced.
progressjoni metastatika tal-marda kienet imwaqqfa u l-permjabilità mikrovaskulari mnaqqsa.

metastatic breast and ovarian cancer (second-line treatment):
kanċer tas- sider fi stat metastatiku u kanċer ta ’ l- ovarju fi stat metastatiku (bħala t- tieni kura preferuta):